Literature DB >> 22553319

Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.

Martha J Lewis1, Patricia Lee, Hwee L Ng, Otto O Yang.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) Nef downregulates major histocompatibility complex class I (MHC-I), impairing the clearance of infected cells by CD8(+) cytotoxic T lymphocytes (CTLs). While sequence motifs mediating this function have been determined by in vitro mutagenesis studies of laboratory-adapted HIV-1 molecular clones, it is unclear whether the highly variable Nef sequences of primary isolates in vivo rely on the same sequence motifs. To address this issue, nef quasispecies from nine chronically HIV-1-infected persons were examined for sequence evolution and altered MHC-I downregulatory function under Gag-specific CTL immune pressure in vitro. This selection resulted in decreased nef diversity and strong purifying selection. Site-by-site analysis identified 13 codons undergoing purifying selection and 1 undergoing positive selection. Of the former, only 6 have been reported to have roles in Nef function, including 4 associated with MHC-I downregulation. Functional testing of naturally occurring in vivo polymorphisms at the 7 sites with no previously known functional role revealed 3 mutations (A84D, Y135F, and G140R) that ablated MHC-I downregulation and 3 (N52A, S169I, and V180E) that partially impaired MHC-I downregulation. Globally, the CTL pressure in vitro selected functional Nef from the in vivo quasispecies mixtures that predominately lacked MHC-I downregulatory function at the baseline. Overall, these data demonstrate that CTL pressure exerts a strong purifying selective pressure for MHC-I downregulation and identifies novel functional motifs present in Nef sequences in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553319      PMCID: PMC3416312          DOI: 10.1128/JVI.00878-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  Live and let die: Nef functions beyond HIV replication.

Authors:  Oliver T Fackler; Andreas S Baur
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

2.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

3.  Human immunodeficiency virus type 1 negative factor is a transcriptional silencer.

Authors:  T M Niederman; B J Thielan; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Subunit H of the V-ATPase binds to the medium chain of adaptor protein complex 2 and connects Nef to the endocytic machinery.

Authors:  Matthias Geyer; Haifeng Yu; Robert Mandic; Thomas Linnemann; Yong-Hui Zheng; Oliver T Fackler; B Matija Peterlin
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

6.  Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR.

Authors:  N Ahmad; S Venkatesan
Journal:  Science       Date:  1988-09-16       Impact factor: 47.728

7.  Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.

Authors:  Hiroko Tomiyama; Hirofumi Akari; Akio Adachi; Masafumi Takiguchi
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations.

Authors:  Ayub Ali; Satish Pillai; Hwee Ng; Rachel Lubong; Douglas D Richman; Beth D Jamieson; Yan Ding; M Juliana McElrath; John C Guatelli; Otto O Yang
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

9.  Half-genome human immunodeficiency virus type 1 constructs for rapid production of reporter viruses.

Authors:  Ayub Ali; Beth D Jamieson; Otto O Yang
Journal:  J Virol Methods       Date:  2003-06-30       Impact factor: 2.014

10.  Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.

Authors:  Otto O Yang; Phuong Thi Nguyen Sarkis; Ayub Ali; Jason D Harlow; Christian Brander; Spyros A Kalams; Bruce D Walker
Journal:  J Exp Med       Date:  2003-05-12       Impact factor: 14.307

View more
  14 in total

1.  Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.

Authors:  Mako Toyoda; Yoko Ogata; Macdonald Mahiti; Yosuke Maeda; Xiaomei T Kuang; Toshiyuki Miura; Heiko Jessen; Bruce D Walker; Mark A Brockman; Zabrina L Brumme; Takamasa Ueno
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 2.  Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.

Authors:  Nadia T Sebastian; Kathleen L Collins
Journal:  Expert Rev Anti Infect Ther       Date:  2014-09-04       Impact factor: 5.091

3.  HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.

Authors:  Zachary Ende; Martin J Deymier; Daniel T Claiborne; Jessica L Prince; Daniela C Mónaco; William Kilembe; Susan A Allen; Eric Hunter
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction.

Authors:  Justin De La Cruz; Thomas Vollbrecht; Patricia Frohnen; Hwee L Ng; Eric S Daar; Otto O Yang; Martha J Lewis
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

5.  Impaired Nef function is associated with early control of HIV-1 viremia.

Authors:  Xiaomei T Kuang; Xiaoguang Li; Gursev Anmole; Philip Mwimanzi; Aniqa Shahid; Anh Q Le; Louise Chong; Hua Qian; Toshiyuki Miura; Tristan Markle; Bemuluyigza Baraki; Elizabeth Connick; Eric S Daar; Heiko Jessen; Anthony D Kelleher; Susan Little; Martin Markowitz; Florencia Pereyra; Eric S Rosenberg; Bruce D Walker; Takamasa Ueno; Zabrina L Brumme; Mark A Brockman
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

Review 6.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

7.  Brain-specific HIV Nef identified in multiple patients with neurological disease.

Authors:  Susanna L Lamers; Gary B Fogel; Enoch S Liu; Andrew E Barbier; Christopher W Rodriguez; Elyse J Singer; David J Nolan; Rebecca Rose; Michael S McGrath
Journal:  J Neurovirol       Date:  2017-10-23       Impact factor: 2.643

8.  In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.

Authors:  Richard L Watkins; John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2015-07-14       Impact factor: 4.602

Review 9.  Human leukocyte antigen (HLA) class I down-regulation by human immunodeficiency virus type 1 negative factor (HIV-1 Nef): what might we learn from natural sequence variants?

Authors:  Philip Mwimanzi; Tristan J Markle; Takamasa Ueno; Mark A Brockman
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

10.  Attenuation of multiple Nef functions in HIV-1 elite controllers.

Authors:  Philip Mwimanzi; Tristan J Markle; Eric Martin; Yoko Ogata; Xiaomei T Kuang; Michiyo Tokunaga; Macdonald Mahiti; Florencia Pereyra; Toshiyuki Miura; Bruce D Walker; Zabrina L Brumme; Mark A Brockman; Takamasa Ueno
Journal:  Retrovirology       Date:  2013-01-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.